Tumor Uptake of (64)Cu-DOTA-Trastuzumab in Patients with Metastatic Breast Cancer

The goal of this study was to characterize the relationship between tumor uptake of (64)Cu-DOTA-trastuzumab as measured by PET/CT and standard, immunohistochemistry (IHC)-based, histopathologic classification of human epidermal growth factor receptor 2 (HER2) status in women with metastatic breast c...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Nucl Med
Main Authors: Mortimer, Joanne E., Bading, James R., Park, Jinha M., Frankel, Paul H., Carroll, Mary I., Tran, Tri T., Poku, Erasmus K., Rockne, Russell C., Raubitschek, Andrew A., Shively, John E., Colcher, David M.
Format: Artigo
Jezik:Inglês
Izdano: Society of Nuclear Medicine 2018
Teme:
Oncology
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5750523/
https://ncbi.nlm.nih.gov/pubmed/28637802
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2967/jnumed.117.193888
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki